pharmacogenomics - American Pharmacogenomics Association

Education

What is “Omics” and is Pharmacogenomics a Part of It?

Posted onJuly 24, 2024July 24, 2024

In the realm of medical research, a novel domain has surfaced – “omics.” It encompasses the in-depth study of biological molecules, including genes,…

Posted onJune 24, 2024June 24, 2024

Explore the synergy between PGx and the Microbiome to unlock the secrets of gut health’s role in shaping personalized drug responses.

Posted onJune 20, 2024June 20, 2024

Unlock personalized dosing for safer antiplatelet therapy with pharmacogenomics, reducing bleeding risks in cardiovascular care.

Posted onJune 12, 2024June 12, 2024

Unlock personalized medicine with PGx Testing – revolutionizing drug development and optimizing clinical trials for tailored treatments.

Posted onJune 11, 2024June 11, 2024

Explore how Polygenic Risk Scores enhance personalized medicine by predicting medication side effects and disease susceptibility.

Posted onMay 27, 2024June 11, 2024

Explore how PGx and Factor V Leiden intertwine to influence medication efficacy and safety for those with genetic clotting disorders.

Posted onMay 22, 2024May 22, 2024

Discover why PGx patients facing resistance and the importance of bridging the educational gap in precision medicine for enhanced patient care.

Posted onMay 18, 2024June 11, 2024

Discover how CYP2C9 genetic variations impact warfarin sensitivity and can guide personalized anticoagulant therapy for better patient outcomes.

Gated Content

Posted onMay 13, 2024May 13, 2024

Uncover how preemptive genetic testing for TPMT and NUDT15 can guide safer drug use and individualized patient care.

Posted onApril 24, 2024June 11, 2024

Explore the intersection of personalized medicine and pharmacogenomics, where tailored treatments meet genetic understanding.